Hindustan Institute Of Pharmakon Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 01-07-2024
- Paid Up Capital ₹ 1.25 Cr
as on 01-07-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.05 Cr
as on 01-07-2024
- Revenue %
(FY 2022)
- Profit 3.88%
(FY 2022)
- Ebitda
- Net Worth -0.16%
(FY 2022)
- Total Assets -0.13%
(FY 2022)
About Hindustan Institute Of Pharmakon
The Corporate was formerly known as Hindustan Institute Of Pharmakon Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company has closed loans amounting to ₹6.05 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashok Nanda, Alok Nanda, and Jasbir Nanda serve as directors at the Company.
- CIN/LLPIN
U33112MP1993PTC008028
- Company No.
008028
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hindustan Institute Of Pharmakon?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Nanda  | Managing Director | 28-Dec-1993 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alok Nanda | Director | 30-Sep-2003 | Current |
| Jasbir Nanda | Director | 28-Dec-1993 | Current |
Financial Performance of Hindustan Institute Of Pharmakon.
Hindustan Institute Of Pharmakon Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.88% increase in profit. The company's net worth dipped by a decrease of 0.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hindustan Institute Of Pharmakon?
In 2020, Hindustan Institute Of Pharmakon had a promoter holding of 66.10% and a public holding of 33.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
International Public School Private LimitedActive 14 years 2 monthsAshok Nanda, Alok Nanda and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 30 Mar 2012 | ₹1.00 Cr | Satisfied |
Allahabad Bank Creation Date: 27 Jan 2010 | ₹1.00 M | Satisfied |
B H W Home Finance Limited Creation Date: 31 Aug 2008 | ₹5.00 M | Satisfied |
How Many Employees Work at Hindustan Institute Of Pharmakon?
Unlock and access historical data on people associated with Hindustan Institute Of Pharmakon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindustan Institute Of Pharmakon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Institute Of Pharmakon's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
